tiprankstipranks
Trending News
More News >
Heidelberg Pharma AG (GB:0QW5)
LSE:0QW5
UK Market

Heidelberg Pharma AG (0QW5) Income Statement

Compare
0 Followers

Heidelberg Pharma AG Income Statement

Last quarter (Q3 2025), Heidelberg Pharma AG's total revenue was €47.13K, a decrease of -96.05% from the same quarter last year. In Q3, Heidelberg Pharma AG's net income was €-8.46M. See Heidelberg Pharma AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 6.85M€ 9.86M€ 18.51M€ 1.75M€ 8.49M
Gross Profit
€ 4.20M€ 6.61M€ 13.83M€ -2.96M€ 2.89M
Operating Expenses
€ 25.73M€ 27.82M€ 32.17M€ 22.83M€ 21.45M
Depreciation and Amortization
€ 871.22K€ 879.00K€ 756.58K€ 802.86K€ 734.00K
EBITDA
€ -18.37M€ -18.71M€ -16.19M€ -24.83M€ -17.55M
Operating Income
€ -24.56M€ -21.21M€ -18.33M€ -25.63M€ -18.56M
Other Income/Expenses
€ 1.28M€ 863.31K€ -604.67K€ -507.64K€ -84.32K
Pretax Income
€ -19.38M€ -20.35M€ -17.79M€ -26.14M€ -18.37M
Net Income
€ -19.38M€ -20.35M€ -19.70M€ -26.63M€ -18.37M
Per Share Metrics
Basic EPS
€ -0.42€ -0.44€ -0.53€ -0.82€ -0.61
Diluted EPS
€ -0.42€ -0.44€ -0.53€ -0.82€ -0.61
Weighted Average Shares Outstanding
46.60M 46.60M 37.24M 32.50M 29.90M
Weighted Average Shares Outstanding (Diluted)
46.60M 46.60M 37.24M 32.50M 29.90M
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History